From The Times of Israel:
A breakthrough cancer study in which patients suffering from a form of leukemia saw their diseases go into remission after they were treated with genetically modified T-cells has deep roots in Israel.
One of the first in the world to work on the innovative adaptive immunotherapy technique to treat cancer, which was hailed Tuesday worldwide as a potentially “extraordinary” development, was Weizmann University Professor Zelig Eshhar. Speaking Wednesday on Israel Radio, Eshhar said he was very heartened to hear about the results of the study at the University of Pennsylvania.
“I’m not surprised to hear about the results,” he said. “In our lab, we cured many rats and mice of cancer. I have been saying for years that we could do this in people, as well.”
Read more here.
The words of this author reflect his/her own opinions and do not necessarily represent the official position of the Orthodox Union.